Ahmed M Soliman1, Hugh S Taylor2, Machaon Bonafede3, James K Nelson3, Jane Castelli-Haley4. 1. AbbVie, North Chicago, Illinois. Electronic address: ahmed.m.soliman@abbvie.com. 2. Yale School of Medicine, New Haven, Connecticut. 3. Truven Health Analytics, an IBM company, Ann Arbor, Michigan. 4. AbbVie, North Chicago, Illinois.
Abstract
OBJECTIVE: To compare direct and indirect costs between endometriosis patients who underwent endometriosis-related surgery (surgery cohort) and those who have not received surgery (no-surgery cohort). DESIGN: Retrospective cohort study. SETTING: Not applicable. PATIENT(S): Endometriosis patients (aged 18-49 years) with (n = 124,530) or without (n = 37,106) a claim for endometriosis-related surgery were identified from the Truven Health MarketScan Commercial and Health and Productivity Management databases for 2006-2014. INTERVENTION(S): Not applicable. MAIN OUTCOME MEASURE(S): Primary outcomes were healthcare utilization during 12-month pre- and post-index periods, annual direct (healthcare) and indirect (absenteeism and short- and long-term disability) costs during the 12-month post-index period (in 2014 US dollars). Indirect costs were assessed for patients with available productivity data. RESULT(S): Patients in the surgery cohort had significantly higher healthcare resource utilization during the post-index period and had mean annual total adjusted post-index direct costs approximately three times the costs among patients in the no-surgery cohort ($19,203 [SD $7,133] vs. $6,365 [SD $2,364]; average incremental annual direct cost = $12,838). The mean cost of surgery ($7,268 [SD $7,975]) was the single largest contributor to incremental annual direct cost. Mean estimated annual total indirect costs were $8,843 (surgery cohort) vs. $5,603 (no-surgery cohort); average incremental annual indirect cost = $3,240. CONCLUSION(S): Endometriosis patients who underwent surgery, compared with endometriosis patients who did not, incurred significantly higher direct costs due to healthcare utilization and indirect costs due to absenteeism or short-term disability. Regardless of the surgery type, the cost of index surgery contributed substantially to the total healthcare expenditure.
OBJECTIVE: To compare direct and indirect costs between endometriosispatients who underwent endometriosis-related surgery (surgery cohort) and those who have not received surgery (no-surgery cohort). DESIGN: Retrospective cohort study. SETTING: Not applicable. PATIENT(S): Endometriosispatients (aged 18-49 years) with (n = 124,530) or without (n = 37,106) a claim for endometriosis-related surgery were identified from the Truven Health MarketScan Commercial and Health and Productivity Management databases for 2006-2014. INTERVENTION(S): Not applicable. MAIN OUTCOME MEASURE(S): Primary outcomes were healthcare utilization during 12-month pre- and post-index periods, annual direct (healthcare) and indirect (absenteeism and short- and long-term disability) costs during the 12-month post-index period (in 2014 US dollars). Indirect costs were assessed for patients with available productivity data. RESULT(S): Patients in the surgery cohort had significantly higher healthcare resource utilization during the post-index period and had mean annual total adjusted post-index direct costs approximately three times the costs among patients in the no-surgery cohort ($19,203 [SD $7,133] vs. $6,365 [SD $2,364]; average incremental annual direct cost = $12,838). The mean cost of surgery ($7,268 [SD $7,975]) was the single largest contributor to incremental annual direct cost. Mean estimated annual total indirect costs were $8,843 (surgery cohort) vs. $5,603 (no-surgery cohort); average incremental annual indirect cost = $3,240. CONCLUSION(S): Endometriosispatients who underwent surgery, compared with endometriosispatients who did not, incurred significantly higher direct costs due to healthcare utilization and indirect costs due to absenteeism or short-term disability. Regardless of the surgery type, the cost of index surgery contributed substantially to the total healthcare expenditure.
Authors: Stephanie J Estes; Ahmed M Soliman; Andrew J Epstein; Julia C Bond; Keith Gordon; Stacey A Missmer Journal: PLoS One Date: 2019-09-19 Impact factor: 3.240
Authors: Stacey A Missmer; Frank F Tu; Sanjay K Agarwal; Charles Chapron; Ahmed M Soliman; Stephanie Chiuve; Samantha Eichner; Idhaliz Flores-Caldera; Andrew W Horne; Alexandra B Kimball; Marc R Laufer; Nicholas Leyland; Sukhbir S Singh; Hugh S Taylor; Sawsan As-Sanie Journal: Int J Gen Med Date: 2021-01-07
Authors: Stacey A Missmer; Frank Tu; Ahmed M Soliman; Stephanie Chiuve; Sarah Cross; Samantha Eichner; Oscar Antunez Flores; Andrew Horne; Beth Schneider; Sawsan As-Sanie Journal: BMJ Open Date: 2022-04-27 Impact factor: 3.006
Authors: Andrew J Epstein; Ahmed M Soliman; Matthew Davis; Scott J Johnson; Michael C Snabes; Eric S Surrey Journal: Adv Ther Date: 2017-11-03 Impact factor: 3.845